Table 4. Number of chlamydia (from any site), HIV tests and anal swabs ordered in CASI (2009) and non-CASI (2008 and 2010) periods.
CASI | non-CASI | |||||||
Test | n | N | % | n | N | % | p-value a | |
Heterosexual men | chlamydia | 607 | 748 | 81 | 1330 | 1643 | 81 | 0.85 |
HIV | 323 | 715 | 45 | 687 | 1551 | 44 | 0.61 | |
MSM | chlamydia | 408 | 441 | 93 | 981 | 1045 | 94 | 0.40 |
HIV | 343 | 436 | 79 | 849 | 1041 | 82 | 0.23 | |
anal swab | 369 | 441 | 84 | 842 | 1045 | 81 | 0.38 | |
Female | chlamydia | 645 | 767 | 84 | 1525 | 1735 | 88 | <0.001 |
HIV | 330 | 751 | 44 | 817 | 1686 | 48 | 0.18 |
Logistic regression for differences in testing rates between CASI and non-CASI periods adjusting for potential intra cluster correlation from individual clinicians. n = number of patients tested; N = number of patients seen during each period. MSM = men who have sex with men.